Psyence Biomedical Ltd.

NASDAQ: PBM · Real-Time Price · USD
3.22
-0.13 (-3.88%)
At close: Aug 15, 2025, 3:59 PM
3.28
1.63%
After-hours: Aug 15, 2025, 07:36 PM EDT

Psyence Biomedical Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2024 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021
Period Ending Sep 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021
Cash & Equivalents
1.93M 733.19 88.17K 9.8K 15.96K 128.68K 214.94K 306.88K 431.9K 648.28K 9.91K
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a 12.52M 16.54M 16.12M 257.73M 255.92M 255.12M 255.01M 255M n/a
Other Long-Term Assets
n/a 0.00 n/a n/a n/a n/a 16.23K 94.41K 171.74K 248.65K 208.06K
Receivables
125.08K n/a 53.66K 67.18K 60.9K n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
29.61K 71.36 n/a n/a n/a n/a n/a n/a n/a 324.94K n/a
Total Current Assets
2.24M 1.13K 162.52K 181.39K 288.6K 1.21M 540.93K 652.54K 797.2K 973.22K 9.91K
Property-Plant & Equipment
10.13K 5.49 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
10.13K 5.49 12.52M 16.54M 16.12M 257.73M 255.94M 255.22M 255.18M 255.25M 208.06K
Total Assets
2.25M 1.13K 12.68M 16.73M 16.4M 258.93M 256.48M 255.87M 255.98M 256.22M 217.98K
Account Payables
805.61K 562.35 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
2.5M 10.45K 1.61M 1.18M 685K n/a n/a n/a n/a n/a 90.09K
Other Current Liabilities
190.11K 968.70 14.57M 14.09M 14.19M 14.27M 187.04K 213.7K 142.67K 68.7K 182.38K
Total Current Liabilities
3.51M 12.1K 16.18M 15.26M 14.88M 14.27M 187.04K 213.7K 142.67K 68.7K 272.47K
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a 13.88M 14.01M 16.24M 19.51M n/a
Total Long-Term Liabilities
n/a n/a n/a n/a n/a n/a 13.88M 14.01M 16.24M 19.51M n/a
Total Liabilities
3.51M 12.1K 16.18M 15.26M 14.88M 14.27M 14.07M 14.23M 16.38M 19.58M 272.47K
Total Debt
2.5M 10.45K 1.61M 1.18M 685K n/a n/a n/a n/a n/a 90.09K
Common Stock
52.94M 46.13K 12.57M 16.61M 16.18M 258.55M 255.92M 255M 255M 255M 661.00
Retained Earnings
-54.5M -57.46K -16.07M -15.15M -14.65M -13.9M -13.51M -13.36M -15.4M -18.36M -79.49K
Comprehensive Income
260.02K 361.06 n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
-1.26M -10.97K -3.5M 1.46M 1.52M 244.66M 242.41M 241.64M 239.6M 236.65M -54.49K
Total Investments
n/a n/a 12.52M 16.54M 16.12M 257.73M 255.92M 255.12M 255.01M 255M n/a